Status:
UNKNOWN
Medical Data Collection for the Evaluation of Radiofrequency Ablation and Cement Augmentation for the Treatment of Secondary Metastases to the Spine
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Metastatic Malignant Neoplasm in the Spine
Eligibility:
All Genders
Brief Summary
This study collects data on the use of radiofrequency ablation and cement augmentation for the treatment of cancer that has spread to the spine (metastases to the spine). Radiofrequency ablation with ...
Detailed Description
PRIMARY OBJECTIVE: I. To evaluate the use of radiofrequency ablation and cement augmentation for the treatment of secondary metastases to the spine. OUTLINE: Patients' medical data is collected ret...
Eligibility Criteria
Inclusion
- Patients who underwent radiofrequency ablation with cement augmentation at the Department of Interventional Radiology at MD Anderson Cancer Center (MDACC) between 1/1/2017 and 9/26/2020
Exclusion
- None
Key Trial Info
Start Date :
November 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2023
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04751422
Start Date
November 13 2020
End Date
September 30 2023
Last Update
April 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030